ifosfamide has been researched along with Cancer of the Fallopian Tube in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Ifosfamide has been shown to possess modest activity in patients with platinum/cyclophosphamide refractory ovarian cancer." | 2.69 | Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent. ( Belinson, J; Hurteau, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Sutton, G; Webster, K, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Markman, M | 1 |
Kennedy, A | 1 |
Sutton, G | 1 |
Hurteau, J | 1 |
Webster, K | 1 |
Peterson, G | 1 |
Kulp, B | 1 |
Belinson, J | 1 |
Halligan, AW | 1 |
McGuinness, EP | 1 |
1 trial available for ifosfamide and Cancer of the Fallopian Tube
Article | Year |
---|---|
Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carboplatin; Cisplatin; Cysta | 1998 |
1 other study available for ifosfamide and Cancer of the Fallopian Tube
Article | Year |
---|---|
Malignant fibrous histiocytoma of the fallopian tube.
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Fallopian Tube Neoplasms; Female; Histio | 1990 |